Antares Vision (AV) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
9 Jun, 2026Executive summary
Orders intake rose 7% year-over-year, with strong growth in Italy (+37%) and Europe (+12%), but declines in the Americas, especially in FMCG.
Revenues reached €87.6M, down 5.7% year-over-year (4.1% like-for-like), mainly due to deconsolidation of AV Russia and T2 Software, scope changes, and weak FMCG performance; no FX impact.
Adjusted EBITDA improved to €3.4M (3.9% margin), up from a loss of €5.3M in 1H 2023, driven by cost reductions, restructuring, and improved efficiency.
Net loss was €22M, impacted by €9.5M in non-recurring costs and restructuring; adjusted net loss narrowed to €6.7M from €13.9M in 1H 2023.
Workforce reduced by 14% to 1,226 employees, following a social plan and reorganisation.
Financial highlights
Revenue: €87.6M (-5.7% year-over-year; -4.1% like-for-like); Adjusted EBITDA: €3.4M (3.9% margin); Adjusted EBIT: -€4.0M.
Net loss: -€22.0M (vs. -€19.2M in 1H 2023); adjusted net loss: -€6.7M (vs. -€13.9M); net financial position: -€98.2M (improved from -€104.3M at YE23).
Gross margin improved to 82.2% (from 78.7% in 1H 2023); value added margin rose to 59.1%.
Cost of goods sold fell 18.3% YoY; personnel and service costs down over 12%.
Operating cash flow was €9M, a significant improvement from -€29M in 1H 2023, driven by better working capital management.
Outlook and guidance
FY 2024 guidance confirmed: revenue growth expected at 4–6%, adjusted EBITDA margin at 11.5–14%, and Net Debt/EBITDA ratio between 4.1x and 3.3x.
2024–2026 business plan targets revenue and adjusted EBITDA CAGR of 4–6% and 47–55%, respectively, with EBITDA margin reaching 17.5–19.5% by 2026.
Management expects improved margins and cash generation through cost discipline and working capital optimisation.
Strategy focuses on cost discipline, cash generation, and selective market expansion.
Management expects continued order growth despite macroeconomic and geopolitical uncertainties.
Latest events from Antares Vision
- FY 2025 revenues fell 2% to €204M, with SCT and recurring revenue growth offsetting Life Science weakness.AV
Q4 202513 Feb 2026 - 9M 2025 revenues up 5% to €134M; FY outlook flat with lower EBITDA margin expected.AV
Q3 202514 Nov 2025 - Orders up 14%, revenues rose 3.3%, EBITDA doubled, and net loss narrowed in 1H 2025.AV
Q2 202512 Sep 2025 - Margins and cash flow improved as orders rose and full-year guidance was confirmed.AV
Q3 202413 Jun 2025 - 2024-2026 plan aims for strong revenue and EBITDA growth, driven by innovation and efficiency.AV
Strategy Update13 Jun 2025 - Q1 2025 orders up 25% year-over-year, with recurring revenues at 49% of total.AV
Q1 20256 Jun 2025 - Profitability and cash flow surged, with recurring revenues and leverage improving.AV
H2 20246 Jun 2025 - Strong 4Q drives revenue, margin, and order growth, setting up a positive 2025 outlook.AV
Q4 2024 TU6 Jun 2025